Chronic pulmonary aspergillosis (CPA) is a long-term fungal lung disease caused by Aspergillus. It can cause cavities and scarring in the lungs, persistent respiratory symptoms and, in some people, haemoptysis (coughing up blood).
New to CPA? Start with our main guide to chronic pulmonary aspergillosis (CPA), which explains what CPA is, how it is diagnosed and how it is treated.
This hub brings together more detailed information about CPA, including antifungal treatment, lung cavities, haemoptysis, symptoms, monitoring and changes seen on CT scans and other imaging.
Understanding antifungal medicines – how they work, their uses and side effects
Need specialist advice?
Find out how to access NHS aspergillosis expertise, including referral to the National Aspergillosis Centre, without necessarily paying for private care.
Can Lung Cavities Heal in Aspergillosis? – Why some lung cavities shrink, why others remain, and how doctors assess treatment success in chronic pulmonary aspergillosis (CPA).
Topics in This Hub
Latest CPA Articles
How Doctors Diagnose Aspergillus Lung Infections
October 15, 2026
What Worries People with CPA Most? Patients Tell Us
October 12, 2026
Aspergillosis research: this week’s update
September 28, 2026
Mick: living with CPA and adapting to change
September 28, 2026
Diabetes and aspergillosis: understanding the connection.
August 13, 2026
Cystic Fibrosis and Aspergillus: When Does It Matter?
August 12, 2026
NTM Lung Disease and Aspergillosis: Why They Can Overlap
August 10, 2026
🌿 Biologics when ABPA and CPA overlap: What Patients Need to Know
November 25, 2025
📘 What is CPA? (Chronic Pulmonary Aspergillosis)
August 7, 2025
🧾 Rezafungin: A New Antifungal Being Trialled for CPA
August 1, 2025
- 1
- 2
Related Hubs
Did this page help you?
Tell us in one minute



























